| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Can We and Should We Improve on Frontline Imatinib Therapy for Chronic Myeloid Leukemia?
|
Fava, Carmen
|
|
2010
|
47 |
4 |
p. 319-326
8 p.
|
artikel
|
| 2 |
Chronic Myeloid Leukemia: A Historical Perspective
|
Goldman, John M.
|
|
2010
|
47 |
4 |
p. 302-311
10 p.
|
artikel
|
| 3 |
Chronic Myeloid Leukemia and Second-Generation Tyrosine Kinase Inhibitors: When, How, and Which One?
|
Jabbour, Elias
|
|
2010
|
47 |
4 |
p. 344-353
10 p.
|
artikel
|
| 4 |
Current Status of Imatinib as Frontline Therapy for Chronic Myeloid Leukemia
|
Marin, David
|
|
2010
|
47 |
4 |
p. 312-318
7 p.
|
artikel
|
| 5 |
Future Issues and Recent Issues
|
|
|
2010
|
47 |
4 |
p. A5-
1 p.
|
artikel
|
| 6 |
Masthead
|
|
|
2010
|
47 |
4 |
p. A2-
1 p.
|
artikel
|
| 7 |
Practical Considerations for Monitoring Patients With Chronic Myeloid Leukemia
|
Branford, Susan
|
|
2010
|
47 |
4 |
p. 327-334
8 p.
|
artikel
|
| 8 |
Previous Issues
|
|
|
2010
|
47 |
4 |
p. A4-
1 p.
|
artikel
|
| 9 |
Resistance to Imatinib: Mutations and Beyond
|
La Rosée, Paul
|
|
2010
|
47 |
4 |
p. 335-343
9 p.
|
artikel
|
| 10 |
Stem Cell Transplant for Chronic Myeloid Leukemia in the Imatinib Era
|
Radich, Jerald
|
|
2010
|
47 |
4 |
p. 354-361
8 p.
|
artikel
|
| 11 |
Table of Contents
|
|
|
2010
|
47 |
4 |
p. A3-
1 p.
|
artikel
|
| 12 |
The Elusive Chronic Myeloid Leukemia Stem Cell: Does It Matter and How Do We Eliminate It?
|
Carter, Bing Z.
|
|
2010
|
47 |
4 |
p. 362-370
9 p.
|
artikel
|
| 13 |
Third-Generation Tyrosine Kinase Inhibitors and Beyond
|
Quintás-Cardama, Alfonso
|
|
2010
|
47 |
4 |
p. 371-380
10 p.
|
artikel
|
| 14 |
Towards a Cure for Chronic Myeloid Leukemia: Are We There Yet?
|
Cortes, Jorge
|
|
2010
|
47 |
4 |
p. 299-301
3 p.
|
artikel
|
Tijdschrift beschrijving